Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
CNY | Fiscal Year Ending | | Latest |
(in millions) | | | | | Jun-19 | Jun-20 | Jun-21 | Jun-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 9,395 | 8,979 | 9,072 | 10,086 | 15,265 | 16,994 | | 16,994 |
% Growth | NA | NA | NA | NA | NA | -4.4% | 1.0% | 11.2% | 51.4% | 11.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | (6,884) | (6,246) | (6,641) | (7,016) | (8,783) | (9,357) | | (9,357) |
Gross Profit | 0 | 0 | 0 | 0 | 2,511 | 2,732 | 2,431 | 3,070 | 6,482 | 7,637 | | 7,637 |
% Revenue | NA | NA | NA | NA | 26.7% | 30.4% | 26.8% | 30.4% | 42.5% | 44.9% | | 44.9% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | (818) | (1,190) | (1,207) | (1,442) | (2,726) | (3,520) | | (3,520) |
General and Admin | 0 | 0 | 0 | 0 | (683) | (822) | (832) | (845) | (720) | (929) | | (929) |
Other Inc / (Exp) | 0 | 0 | 0 | 0 | (704) | (660) | (1,687) | 28 | 43 | (29) | | (29) |
Total Operating Exp | 0 | 0 | 0 | 0 | (2,205) | (2,672) | (3,726) | (2,260) | (3,403) | (4,478) | | (4,478) |
| | | | | | | | | | | | |
Operating Income | 0 | 0 | 0 | 0 | 306 | 60 | (1,295) | 810 | 3,079 | 3,159 | | 3,159 |
% Revenue | NA | NA | NA | NA | 3.3% | 0.7% | -14.3% | 8.0% | 20.2% | 18.6% | | 18.6% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 0 | (17) | 21 | 79 | 97 | 226 | 188 | | 188 |
Pre-tax Income | 0 | 0 | 0 | 0 | 289 | 81 | (1,216) | 907 | 3,305 | 3,348 | | 3,348 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | (304) | (130) | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | 0 | (280) | (211) | (213) | (267) | (793) | (712) | | (712) |
Net Income to Company | 0 | 0 | 0 | 0 | (294) | (260) | (1,429) | 640 | 2,512 | 2,635 | | 2,635 |
% Margin | NA | NA | NA | NA | -3.1% | -2.9% | -15.8% | 6.3% | 16.5% | 15.5% | | 15.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 4 | (2) | 14 | (2) | (15) | (18) | | (18) |
Net Income to Stockholders | 0 | 0 | 0 | 0 | (291) | (262) | (1,415) | 638 | 2,497 | 2,618 | | 2,618 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 320 | 163 | 117 | (2) | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | 0 | 0 | 0 | 30 | (99) | (1,298) | 637 | 2,497 | 2,618 | | 2,618 |
% Margin | NA | NA | NA | NA | 0.3% | -1.1% | -14.3% | 6.3% | 16.4% | 15.4% | | 15.4% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | (0.45) | (4.70) | 2.11 | 8.02 | 8.45 | | 8.45 |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | (0.45) | (4.72) | 2.08 | 8.00 | 8.40 | | 8.40 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 214.31 | 220.17 | 276.09 | 301.38 | 311.23 | 309.85 | | 309.85 |
WA Diluted Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 214.31 | 220.17 | 276.09 | 304.16 | 312.91 | 311.70 | | 311.70 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | 0 | 0 | 0 | 289 | 81 | (1,216) | 907 | 3,305 | 3,348 | | 3,348 |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 17 | (21) | (79) | (97) | (226) | (188) | | (188) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 697 | 666 | 1,743 | (6) | 30 | 28 | | 28 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 26 | 37 | 31 | 59 | 74 | 74 | | 74 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | (1) | 1 | (3) | (6) | (29) | (30) | | (30) |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 2 | 3 | 2 | 6 | 3 | 3 | | 3 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 28 | 37 | 3 | 13 | 9 | 9 | | 9 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | (1) | (0) | | (0) |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | (37) | 0 | (22) | (10) | (15) | | (15) |
Adjusted EBITDA | 0 | 0 | 0 | 0 | 1,056 | 768 | 481 | 870 | 3,156 | 3,227 | | 3,227 |
% Margin | NA | NA | NA | NA | 11.2% | 8.6% | 5.3% | 8.6% | 20.7% | 19.0% | | 19.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | 0 | 0 | 0 | 1,030 | 730 | 451 | 811 | 3,082 | 3,153 | | 3,153 |
% Margin | NA | NA | NA | NA | 11.0% | 8.1% | 5.0% | 8.0% | 20.2% | 18.6% | | 18.6% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | 0 | 0 | 0 | (294) | (260) | (1,429) | 640 | 2,512 | 2,635 | | 2,635 |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 28 | 4 | 2 | 7 | (27) | (34) | | (34) |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | (7) | (1) | (1) | (2) | 7 | 9 | | 9 |
Adjusted Net Income | 0 | 0 | 0 | 0 | (274) | (257) | (1,428) | 645 | 2,492 | 2,610 | | 2,610 |
% Margin | NA | NA | NA | NA | -2.9% | -2.9% | -15.7% | 6.4% | 16.3% | 15.4% | | 15.4% |